306 related articles for article (PubMed ID: 17852436)
1. Evaluation of bone mineral density in children with hemophilia: Mansoura University children hospital (MUCH) experience, Mansoura, Egypt.
Abdelrazik N; Reda M; El-Ziny M; Rabea H
Hematology; 2007 Oct; 12(5):431-7. PubMed ID: 17852436
[TBL] [Abstract][Full Text] [Related]
2. Serum Sclerostin Level and Bone Mineral Density in Pediatric Hemophilic Arthropathy.
El-Mikkawy DME; Elbadawy MA; Abd El-Ghany SM; Samaha D
Indian J Pediatr; 2019 Jun; 86(6):515-519. PubMed ID: 30671760
[TBL] [Abstract][Full Text] [Related]
3. Osteoporosis/osteopenia and hemophilic arthropathy in severe hemophilic patients.
Naderi A; Nikvarz M; Arasteh M; Shokoohi M
Arch Iran Med; 2012 Feb; 15(2):82-4. PubMed ID: 22292576
[TBL] [Abstract][Full Text] [Related]
4. Vitamin D deficiency and osteoporosis in hemophilic children: an intermingled comorbidity.
Eldash HH; Atwa ZT; Saad MA
Blood Coagul Fibrinolysis; 2017 Jan; 28(1):14-18. PubMed ID: 26825623
[TBL] [Abstract][Full Text] [Related]
5. Effect of low-dose factor VIII prophylaxis therapy on bone mineral density and 25(OH) vitamin D level in children with severe haemophilia A.
Gamal Andrawes N; Hashem Fayek M; Salah El-Din N; Atef Mostafa R
Haemophilia; 2020 Mar; 26(2):325-332. PubMed ID: 31884718
[TBL] [Abstract][Full Text] [Related]
6. Reduced bone density among children with severe hemophilia.
Barnes C; Wong P; Egan B; Speller T; Cameron F; Jones G; Ekert H; Monagle P
Pediatrics; 2004 Aug; 114(2):e177-81. PubMed ID: 15286254
[TBL] [Abstract][Full Text] [Related]
7. Long-term prophylaxis in severe haemophilia seems to preserve bone mineral density.
Khawaji M; Akesson K; Berntorp E
Haemophilia; 2009 Jan; 15(1):261-6. PubMed ID: 19149852
[TBL] [Abstract][Full Text] [Related]
8. Inactivity is a risk factor for low bone mineral density among haemophilic children.
Tlacuilo-Parra A; Morales-Zambrano R; Tostado-Rabago N; Esparza-Flores MA; Lopez-Guido B; Orozco-Alcala J
Br J Haematol; 2008 Mar; 140(5):562-7. PubMed ID: 18275434
[TBL] [Abstract][Full Text] [Related]
9. Bone status of children with hemophilia A assessed with quantitative ultrasound sonography (QUS) and dual energy X-ray absorptiometry (DXA).
Christoforidis A; Economou M; Papadopoulou E; Kazantzidou E; Gompakis N; Athanassiou-Metaxa M
J Pediatr Hematol Oncol; 2010 Oct; 32(7):e259-63. PubMed ID: 20736845
[TBL] [Abstract][Full Text] [Related]
10. Comparative study of dual energy X-ray absorptiometry and quantitative ultrasonography with the use of biochemical markers of bone turnover in boys with haemophilia.
Christoforidis A; Economou M; Papadopoulou E; Kazantzidou E; Farmaki E; Tzimouli V; Tsatra I; Gompakis N; Athanassiou-Metaxa M
Haemophilia; 2011 Jan; 17(1):e217-22. PubMed ID: 20825502
[TBL] [Abstract][Full Text] [Related]
11. Osteoporosis in young haemophiliacs from western India.
Nair AP; Jijina F; Ghosh K; Madkaikar M; Shrikhande M; Nema M
Am J Hematol; 2007 Jun; 82(6):453-7. PubMed ID: 17278114
[TBL] [Abstract][Full Text] [Related]
12. [Bone mass in patients with cystic fibrosis of the pancreas. Relationship with anthropometric parameters and genotype].
Yeste D; Liñán S; Cobos N; Gussinyé M; del Río L; Carrascosa A
Med Clin (Barc); 1998 Oct; 111(13):485-8. PubMed ID: 9859064
[TBL] [Abstract][Full Text] [Related]
13. Bone mass and biochemical markers of bone turnover in children and adolescents with chronic immune thrombocytopenia: relation to corticosteroid therapy and vitamin D receptor gene polymorphisms.
Tantawy AA; El Bostany EA; Matter RM; El Ghoroury EA; Ragab S; El Sherif NH
Platelets; 2013; 24(4):282-7. PubMed ID: 22671537
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of bone mineral density in Turkish children with severe haemophilia A: Ankara hospital experience.
Alioglu B; Selver B; Ozsoy H; Koca G; Ozdemir M; Dallar Y
Haemophilia; 2012 Jan; 18(1):69-74. PubMed ID: 21651678
[TBL] [Abstract][Full Text] [Related]
15. Osteoporosis in haemophilia - an underestimated comorbidity?
Wallny TA; Scholz DT; Oldenburg J; Nicolay C; Ezziddin S; Pennekamp PH; Stoffel-Wagner B; Kraft CN
Haemophilia; 2007 Jan; 13(1):79-84. PubMed ID: 17212729
[TBL] [Abstract][Full Text] [Related]
16. RANKL:osteoprotegerin ratio and bone mineral density in children with untreated juvenile dermatomyositis.
Rouster-Stevens KA; Langman CB; Price HE; Seshadri R; Shore RM; Abbott K; Pachman LM
Arthritis Rheum; 2007 Mar; 56(3):977-83. PubMed ID: 17328075
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of bone metabolism in children with acute lymphoblastic leukemia after induction chemotherapy treatment.
Athanassiadou F; Tragiannidis A; Rousso I; Katsos G; Sidi V; Koliouskas D; Papastergiou C; Tsituridis I
Pediatr Hematol Oncol; 2005 Jun; 22(4):285-9. PubMed ID: 16020115
[TBL] [Abstract][Full Text] [Related]
18. X-ray absorptiometry of bone in obese and eutrophic children from Valparaiso, Chile.
Fischer S; Milinarsky A; Giadrosich V; Dib G; Arriagada M; Arinoviche R
J Rheumatol; 2000 May; 27(5):1294-6. PubMed ID: 10813304
[TBL] [Abstract][Full Text] [Related]
19. The effect of long-term growth hormone (GH) treatment on bone mineral density in children with GH deficiency. Role of GH in the attainment of peak bone mass.
Saggese G; Baroncelli GI; Bertelloni S; Barsanti S
J Clin Endocrinol Metab; 1996 Aug; 81(8):3077-83. PubMed ID: 8768878
[TBL] [Abstract][Full Text] [Related]
20. [Accretion of bone mass in patients treated for childhood acute lymphoblastic leukemia].
Muszyńska-Rosłan K; Konstantynowicz J; Krawczuk-Rybak M
Pol Merkur Lekarski; 2007 Oct; 23(136):271-5. PubMed ID: 18293849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
